Benzinga | Nov 4, 2020 04:08PM EST

Flexion Therapeutics Q3 EPS $(0.50) Beats $(0.51) Estimate, Sales $23.66M Beat $23.48M Estimate

Flexion Therapeutics (NASDAQ:FLXN) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.51) by 1.96 percent. This is a 50 percent increase over losses of $(1.00) per share from the same period last year. The company reported quarterly sales of $23.66 million which beat the analyst consensus estimate of $23.48 million by 0.78 percent. This is a 8.62 percent increase over sales of $21.79 million the same period last year.